Outcomes of implant-based oral rehabilitation in head and neck oncology patients—a retrospective evaluation of a large, single regional service cohort

International Journal of Implant Dentistry

Table 6 Chemotherapy agents used within the study population

Chemotherapy agents	No. of patients
Carboplatin	13
Cisplatin	10
Cetuximab	2
MAP chemo (methotrexate, doxorubicin, cisplatin)	2
R-CHOP (rituximab, cyclophosphoamide, doxorubicin, vincristine, prednisolone)	1
TPF (docetaxel, cisplatin, 5-fluorouracil)	1
Carboplatin and paclitaxel	1
Total	30

The drugs and regimes of chemotherapy agents used within the study population in the management of their head and neck cancer